HLA in transplantation

Area of Science:

• Immunogenetics
• Transplantation Immunology

Background:

• The human major histocompatibility complex (MHC) encodes human leukocyte antigens (HLAs), critical for immune responses against pathogens and tumors.
• In transplantation, HLAs act as polymorphic antigens triggering immune responses and potential rejection.
• Sensitization to HLAs significantly reduces transplantation access for many patients.

Purpose of the Study:

• To review advancements in HLA understanding and technology.
• To highlight how these advancements improve organ transplantation safety and accessibility.
• To discuss novel strategies for overcoming HLA barriers in transplantation.

Main Methods:

• Review of immunogenetic knowledge and technological progress in HLA detection and tracking.
• Analysis of new approaches in plasmapheresis, intravenous immunoglobulin, and kidney paired donation.
• Examination of novel protocols for tolerance induction and immunomodulation.

Main Results:

• Significant enhancements in transplantation safety due to immunogenetic advances.
• Improved detection and tracking of anti-HLA antibodies facilitate crossing the HLA barrier.
• New desensitization and immunomodulation strategies are emerging.

Conclusions:

• Progress in HLA understanding has made organ transplantation more accessible, even for sensitized individuals.
• Novel desensitization, immunomodulation, and tolerance induction approaches hold potential for further improving transplant access and outcomes.
• Continued research in HLA technology is vital for advancing transplantation medicine.